Cargando…

Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer.

The frequency and severity of fatty infiltration of the liver in patients receiving 5-fluorouracil (5-FU) and folinic acid has not been documented systematically. Its development can result in difficulty assessing disease progression, and treatment may be altered inappropriately. Twenty-seven patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Peppercorn, P. D., Reznek, R. H., Wilson, P., Slevin, M. L., Gupta, R. K.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1998
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150330/
https://www.ncbi.nlm.nih.gov/pubmed/9667683
_version_ 1782144601215205376
author Peppercorn, P. D.
Reznek, R. H.
Wilson, P.
Slevin, M. L.
Gupta, R. K.
author_facet Peppercorn, P. D.
Reznek, R. H.
Wilson, P.
Slevin, M. L.
Gupta, R. K.
author_sort Peppercorn, P. D.
collection PubMed
description The frequency and severity of fatty infiltration of the liver in patients receiving 5-fluorouracil (5-FU) and folinic acid has not been documented systematically. Its development can result in difficulty assessing disease progression, and treatment may be altered inappropriately. Twenty-seven patients with colon cancer and liver metastases receiving 5-FU and folinic acid were studied with computerized tomography (CT) before treatment and after six or 12 cycles of chemotherapy. Forty-seven per cent of patients developed hepatic steatosis during treatment. There was no correlation between development of hepatic steatosis and the dose of chemotherapy or the liver function tests. Hepatic steatosis occurs commonly in patients receiving 5-FU and folinic acid and can be severe. Its development can make hepatic metastases difficult to assess and if its benign nature is not appreciated treatment may be inappropriately altered. IMAGES:
format Text
id pubmed-2150330
institution National Center for Biotechnology Information
language English
publishDate 1998
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-21503302009-09-10 Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer. Peppercorn, P. D. Reznek, R. H. Wilson, P. Slevin, M. L. Gupta, R. K. Br J Cancer Research Article The frequency and severity of fatty infiltration of the liver in patients receiving 5-fluorouracil (5-FU) and folinic acid has not been documented systematically. Its development can result in difficulty assessing disease progression, and treatment may be altered inappropriately. Twenty-seven patients with colon cancer and liver metastases receiving 5-FU and folinic acid were studied with computerized tomography (CT) before treatment and after six or 12 cycles of chemotherapy. Forty-seven per cent of patients developed hepatic steatosis during treatment. There was no correlation between development of hepatic steatosis and the dose of chemotherapy or the liver function tests. Hepatic steatosis occurs commonly in patients receiving 5-FU and folinic acid and can be severe. Its development can make hepatic metastases difficult to assess and if its benign nature is not appreciated treatment may be inappropriately altered. IMAGES: Nature Publishing Group 1998-06 /pmc/articles/PMC2150330/ /pubmed/9667683 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Peppercorn, P. D.
Reznek, R. H.
Wilson, P.
Slevin, M. L.
Gupta, R. K.
Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer.
title Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer.
title_full Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer.
title_fullStr Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer.
title_full_unstemmed Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer.
title_short Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer.
title_sort demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150330/
https://www.ncbi.nlm.nih.gov/pubmed/9667683
work_keys_str_mv AT peppercornpd demonstrationofhepaticsteatosisbycomputerizedtomographyinpatientsreceiving5fluorouracilbasedtherapyforadvancedcolorectalcancer
AT reznekrh demonstrationofhepaticsteatosisbycomputerizedtomographyinpatientsreceiving5fluorouracilbasedtherapyforadvancedcolorectalcancer
AT wilsonp demonstrationofhepaticsteatosisbycomputerizedtomographyinpatientsreceiving5fluorouracilbasedtherapyforadvancedcolorectalcancer
AT slevinml demonstrationofhepaticsteatosisbycomputerizedtomographyinpatientsreceiving5fluorouracilbasedtherapyforadvancedcolorectalcancer
AT guptark demonstrationofhepaticsteatosisbycomputerizedtomographyinpatientsreceiving5fluorouracilbasedtherapyforadvancedcolorectalcancer